<DOC>
	<DOC>NCT00412789</DOC>
	<brief_summary>The study will evaluate the safety and efficacy of Patupilone in adult patients with advanced solid tumors.</brief_summary>
	<brief_title>Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan</brief_title>
	<detailed_description />
	<mesh_term>Epothilone B</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Inclusion criteria: Patients with a histologically/cytologically confirmed diagnosis of advanced solid tumors refractory to or unsuitable for standard therapy, or for whom no standard therapy exists Patients with WHO Performance Status of 01 ( Karnofsky Performance Status of 80100) At least one measurable lesion Exclusion criteria: Patients with any peripheral neuropathy Patients with unresolved diarrhea Patients with severe and/or uncontrolled medical conditions or infections that require systemic therapy Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Advanced solid tumor</keyword>
	<keyword>Patupilone</keyword>
</DOC>